These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6321670)

  • 21. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy.
    Lyman GH; Williams CC; Preston D
    N Engl J Med; 1980 Jan; 302(5):257-60. PubMed ID: 6243170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-cell lung cancer, high growth rate, high response rate to chemotherapy: ideal for high-dose chemotherapy?
    Galani E; Ellis PA; Harper PG
    J Clin Oncol; 2002 Oct; 20(19):3941-3. PubMed ID: 12351589
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
    Johnson DH; DeLeo MJ; Hande KR; Wolff SN; Hainsworth JD; Greco FA
    J Clin Oncol; 1987 May; 5(5):703-9. PubMed ID: 3033161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
    Tjan-Heijnen VC; Biesma B; Festen J; Splinter TA; Cox A; Wagener DJ; Postmus PE
    J Clin Oncol; 1998 Aug; 16(8):2708-14. PubMed ID: 9704721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.
    Havsteen H; Sörenson S; Rørth M; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1981; 65(1-2):123-5. PubMed ID: 6261945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study.
    Grunberg SM; Crowley J; Hande KR; Giroux D; Munshi N; Lau DH; Schroder LE; Zangmeister MH; Balcerzak SP; Hynes HE; Gandara DR
    Cancer Chemother Pharmacol; 1999; 44(6):461-8. PubMed ID: 10550566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung.
    Ettinger DS; Karp JE; Abeloff MD; Burke PJ; Braine HG
    Cancer Treat Rep; 1978 Mar; 62(3):413-24. PubMed ID: 348309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
    Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
    Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W; Izycki T; Ossolinska M; Chyczewska E
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cyclophosphamide in small-cell carcinoma of the lung.
    Souhami RL; Finn G; Gregory WM; Birkhead BG; Buckman R; Edwards D; Goldstone AH; Harper PG; Spiro SG; Tobias JS
    J Clin Oncol; 1985 Jul; 3(7):958-63. PubMed ID: 2991476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
    Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
    Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of relapse in patients with small cell carcinoma of the lung treated with adriamycin-cyclophosphamide chemotherapy and radiation therapy.
    McMahon LJ; Herman TS; Manning MR; Dean JC
    Cancer Treat Rep; 1979 Mar; 63(3):359-62. PubMed ID: 218736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy of small cell carcinomas of the lung].
    Flicker M; Neumann M
    Wien Med Wochenschr; 1983 Aug; 133(15-16):397-402. PubMed ID: 6314680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
    Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M
    Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536
    [No Abstract]   [Full Text] [Related]  

  • 39. [A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung].
    Adachi K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Nakata H; Tada A; Aiba K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1617-22. PubMed ID: 6089668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer.
    Vigani A; Pensa F; Vaira F; Bancalari L; Cordani S; Maggiani R; Canessa P; Pronzato P
    Anticancer Res; 2000; 20(5C):4015-8. PubMed ID: 11268494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.